After a long battle with reviewers and editors we've got our latest paper accepted by Endocrine Connections. I summarise the conclusions. The paper will be published online in the next 7 days.
The findings of the present study have several clinical implications. Firstly, they recognize
thyroid hormone conversion efficiency, as defined by the calculated global deiodinase
activity or more simply the T3-T4 ratio, is an important determinant of L-T4 dose
requirements and the biochemical response to treatment. Secondly, in view of a T4-related
FT3-TSH disjoint FT3 measurement should be adopted as an additional treatment target.
Thirdly, in cases where an FT3-FT4 dissociation becomes increasingly apparent following
dose escalation of L-T4 an alternate treatment modality, possibly T3/T4 combination
therapy, should be considered, but further randomized controlled trials are required to assess the benefit versus risk in this particular group.
By global deiodinase we mean the total deiodinase activity in the body, whether directly acting in the thyroid gland itself or anywhere else in the body. By FT3-TSH disjoint we mean a change in the relation between FT3 and TSH in treated people as compared with normal health.
Written by
diogenes
Remembering
To view profiles and participate in discussions please or .
This is a much harder path! It's (relatively) easy putting down one smaller marker after another in separate papers which together make a story. Critics are like plucking geese - don't take too much at once or they'll squawk. But try to show their overall nakedness in an all encompassing resumee which shows the outcome of all the separate endeavours put together, and the outraged denying/squawking becomes deafening. Joking apart, Dr Dietrich is putting together a group response in a journal which involves others as well, and would include our overarching review of the totality of the implications. But this won't bear fruit until the start of next year I fear..
Yes it is, but drawing together all the strands of argument is what is wanted, to justify in the deepest scientific analytical proof, that the response of those whose thyroids are compromised or lost to therapy requires careful understanding of the large variation in natural thyroid control of the body (patient to patient) and the resulting intelligent diagnosis and treatment schedules needs to satisfy the individual. Less pompously, whether you can handle T4 alone, a T3/T4 combination therapy or T3 only is a matter of resolving personal genetic makeup and suitable response to therapy.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.